SCHEMBL19619218

SCHEMBL19619218

[N-]=[N+]=NC1CC(N=[N+]=[N-])[C@@H](O[C@H]2OC3COC4(CCCCC4)O[C@H]3C(OCOC3C(N=[N+]=[N-])[C@@H](O[C@@H]4C(N=[N+]=[N-])CC(N=[N+]=[N-])C5OC6(CCCCC6)OC54)OC4COC5(CCCCC5)O[C@H]43)C2N=[N+]=[N-])C2OC3(CCCCC3)OC12

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13873397 1.00 — —
SCHEMBL14394321 1.00 — —
SCHEMBL16882146 1.00 — —
SCHEMBL13873339 1.00 — —
SCHEMBL16882161 1.00 — —
SCHEMBL17323706 0.95 — —
SCHEMBL17320684 0.95 — —
SCHEMBL13890107 0.89 — —
SCHEMBL19619209 0.89 — —
SCHEMBL16882152 0.89 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9821001-B2 Aminoglycosides and uses thereof in the treatment of genetic disorders TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (IL) 2017-11-21 — — US disclosed
Send feedback